Shanghai Xuerong Bio-Technology Co Ltd (300511) — Net Asset Quality Index
Shanghai Xuerong Bio-Technology Co Ltd (300511) has a Net Asset Quality Index of 32.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.61 Billion minus total liabilities of CN¥2.43 Billion yields net assets of CN¥1.17 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 300511 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shanghai Xuerong Bio-Technology Co Ltd Net Asset Quality Index Over Time (2012–2024)
This chart shows how Shanghai Xuerong Bio-Technology Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of June 2025, the index stands at 32.5%, representing net assets of CN¥1.17 Billion against total assets of CN¥3.61 Billion CNY. Explore 300511 cash flow metrics to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Shanghai Xuerong Bio-Technology Co Ltd (300511) market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 21.4% | CN¥823.32 Million | CN¥3.85 Billion | CN¥3.03 Billion | ▼ -9.8 pp |
| 2023 | 31.1% | CN¥1.43 Billion | CN¥4.60 Billion | CN¥3.17 Billion | ▼ -8.8 pp |
| 2022 | 39.9% | CN¥1.63 Billion | CN¥4.07 Billion | CN¥2.45 Billion | ▲ +1.8 pp |
| 2021 | 38.1% | CN¥1.65 Billion | CN¥4.34 Billion | CN¥2.69 Billion | ▼ -6.2 pp |
| 2020 | 44.3% | CN¥2.02 Billion | CN¥4.56 Billion | CN¥2.54 Billion | ▼ -1.0 pp |
| 2019 | 45.3% | CN¥1.74 Billion | CN¥3.84 Billion | CN¥2.10 Billion | ▲ +5.0 pp |
| 2018 | 40.3% | CN¥1.57 Billion | CN¥3.89 Billion | CN¥2.32 Billion | ▲ +3.4 pp |
| 2017 | 36.9% | CN¥1.42 Billion | CN¥3.84 Billion | CN¥2.42 Billion | ▼ -15.5 pp |
| 2016 | 52.4% | CN¥1.29 Billion | CN¥2.46 Billion | CN¥1.17 Billion | ▲ +16.2 pp |
| 2015 | 36.2% | CN¥642.99 Million | CN¥1.77 Billion | CN¥1.13 Billion | ▲ +2.1 pp |
| 2014 | 34.2% | CN¥529.00 Million | CN¥1.55 Billion | CN¥1.02 Billion | ▲ +4.5 pp |
| 2013 | 29.6% | CN¥433.49 Million | CN¥1.46 Billion | CN¥1.03 Billion | ▲ +2.6 pp |
| 2012 | 27.0% | CN¥381.15 Million | CN¥1.41 Billion | CN¥1.03 Billion | — |